Sami Caner

Sami Caner currently serves as a Senior International Key Account Manager at AMW GmbH, where he leverages his extensive scientific background and strategic business expertise to drive global growth and foster strong client relationships. In this role, Sami is responsible for managing and expanding key accounts across diverse markets, ensuring that AMW’s innovative drug delivery solutions via biodegradable implants meet the evolving needs of pharmaceutical partners worldwide. His deep understanding of biochemistry, molecular biology, and structural biology—grounded in his PhD research at ETH Zurich—enables him to effectively communicate complex scientific concepts to clients, facilitating collaborative development and tailored solutions in controlled drug release.

Sami’s expertise in account management, combined with his proficiency in direct sales and life sciences, positions him as a vital bridge between R&D, regulatory, and commercial teams. He actively contributes to strategic project planning, identifying new market opportunities, and providing technical support during product integration and deployment. His background in protein chemistry, molecular cloning, and X-ray crystallography allows him to understand and articulate the scientific nuances of AMW’s proprietary biodegradable implants, ensuring clients are well-informed and confident in the technology.

Beyond client engagement, Sami plays a key role in mentoring colleagues and fostering a culture of innovation within the company. His ability to translate complex scientific data into compelling value propositions has been instrumental in establishing AMW’s reputation as a leader in long-acting injectable drug delivery systems. With a focus on expanding AMW’s global footprint, Sami’s combination of scientific rigor and strategic insight continues to drive the company’s mission to improve patient outcomes through innovative pharmaceutical solutions.